The British Medical Association BMA is urging its members not to be involved in any aspect of the NHS Federated Data Platform (FDP) outside of direct patient care because of its link with US technology company Palantir. In 2023, the UK government awarded a seven-year, £330 million contract to a Palantir-led consortium to deliver this platform to link health information in the NHS. The BMA has pledged to issue new guidance to members on alternative options in due course and called for early withdrawal from the platform. BMA board chairman Tom Dolphin said Palantir had a track record of risks including data and patient security disputes in the NHS. The BMA believes there must be a complete divestment from Palantir technologies in the NHS and no further contracts will be awarded. Palantir is a software and data analytics company that provides tools for data integration.